Intensity Therapeutics, financial indicator trend analysis is infinitely more than just investigating Intensity Therapeutics, recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Intensity Therapeutics, is a good investment. Please check the relationship between Intensity Therapeutics, Total Liab and its Capital Stock accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Intensity Therapeutics, Common. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
Total Liab vs Capital Stock
Total Liab vs Capital Stock Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Intensity Therapeutics, Total Liab account and Capital Stock. At this time, the significance of the direction appears to have weak contrarian relationship.
The correlation between Intensity Therapeutics,'s Total Liab and Capital Stock is -0.11. Overlapping area represents the amount of variation of Total Liab that can explain the historical movement of Capital Stock in the same time period over historical financial statements of Intensity Therapeutics, Common, assuming nothing else is changed. The correlation between historical values of Intensity Therapeutics,'s Total Liab and Capital Stock is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Liab of Intensity Therapeutics, Common are associated (or correlated) with its Capital Stock. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Capital Stock has no effect on the direction of Total Liab i.e., Intensity Therapeutics,'s Total Liab and Capital Stock go up and down completely randomly.
The total amount of all liabilities that a company has, including both short-term and long-term liabilities.
Capital Stock
The total amount of a company's capital funded by shareholders through the issue and subscription of shares.
Most indicators from Intensity Therapeutics,'s fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Intensity Therapeutics, current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Intensity Therapeutics, Common. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
When running Intensity Therapeutics,'s price analysis, check to measure Intensity Therapeutics,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Intensity Therapeutics, is operating at the current time. Most of Intensity Therapeutics,'s value examination focuses on studying past and present price action to predict the probability of Intensity Therapeutics,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Intensity Therapeutics,'s price. Additionally, you may evaluate how the addition of Intensity Therapeutics, to your portfolios can decrease your overall portfolio volatility.